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Hypoglycemia in Hospice Patients With Type 2 Diabetes in a National Sample of Nursing Homes
Approximately one-quarter of the US population die in nursing homes, 1 where end-of-life care is of variable quality. 2 In particular, it is unknown whether patients with chronic illness, such as diabetes, continue to receive burdensome testing and treatment after transitioning to hospice care in nursing homes. Experts and the American Diabetes Association recommend relaxing glycemic control target levels for patients with diabetes and advanced disease and eventual discontinuation of medications as patients near death to avoid hypoglycemia. 3, 4 Hypoglycemia causes symptoms of weakness, diaphoresis, confusion, shakiness, and dizziness, 5 and is a potentially preventable cause of suffering among hospice patients. Whether nursing home patients with type 2 diabetes on hospice are assessed for dysglycemia, receive insulin or oral hypoglycemic medications, or experience hypoglycemia and hyperglycemia has not previously been described. Results | The study cohort included 20 329 hospice patients (Table) , 98% of whom were men (n = 19 991). Hospice patients had an 83% 100-day mortality rate (n = 16 791 deaths), and a median length of stay of 10 days. Eight percent of patients in the cohort received insulin (n = 1687). Among patients treated with insulin, mean baseline glycated hemoglobin levels were higher than patients not treated with insulin (7.4% vs 6.8%; P < .001), and the mortality rate at 100 days was lower (61% vs 85%; P < .001).
Patients treated with insulin had more frequent glucose tests (mean 1.7 glucose tests/d, vs 0.6 glucose tests/d among patients not treated with insulin; P < .001). The cumulative incidence of hypoglycemia (glucose <70 mg/dL) among all patients, accounting for the competing risk of death, was 12% at 180 days, and that of severe hypoglycemia (glucose <50 mg/dL) was 5% ( Figure) . Among patients treated with insulin, 38% experienced hypoglycemia and 18% experienced severe hypoglycemia at 180 days. The highest risk of hypoglycemia occurred in the first 20 days of admission. The cumulative incidence of hyperglycemia (glucose >400 mg/dL) at 180 days was 9% in all patients, higher in the group treated with insulin (35%).
Discussion | Despite guidelines that stress avoiding hypoglycemia in hospice patients with diabetes, 4 we found that 1 in 9 nursing home patients with type 2 diabetes experienced hypoglycemia (glucose <70 mg/dL) while 1 in 20 experienced severe hypoglycemia (glucose <50 mg/dL) while on hospice. The risk of hypoglycemia was highest among patients treated with insulin, one-third of whom experienced hypoglycemia. Patients treated with insulin lived longer and experienced more hyperglycemia than patients not treated with insulin, which suggests that clinicians may be choosing to continue insulin for those hospice patients with a longer life expectancy and more severe diabetes at hospice admission. Nevertheless, hypoglycemia is not consistent with a goal of comfort, and these data demonstrate suboptimal avoidance of dysglycemia Glucose <400 mg/dL Cumulative incidence of severe hypoglycemia (glucose <50 mg/dL [to convert to mmol/L, multiply by 0.0555]), hypoglycemia (glucose <70 mg/dL) and hyperglycemia (glucose Ն400 mg/dL) in (A) all veteran patients with type 2 diabetes on hospice in nursing homes; (B) hospice patients treated with insulin; and (C) hospice patients not treated with insulin. Each outcome is shown with competing risk of death over 180 days.
Letters among patients with type 2 diabetes on hospice in nursing homes. Further research is needed to establish optimal timing of diabetes medication titration and cessation and characterize the effect of hypoglycemia and hyperglycemia on the symptom burden of patients with diabetes on hospice.
Association of Veterans Health Administration Home-Based Programs With Access to and Participation in Cardiac Rehabilitation
Performance measures recommend referral to cardiac rehabilitation (CR) after acute myocardial infarction (AMI), percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG), 1 but CR is vastly underused. 2 Lack of transportation and limited access to CR programs have been identified as 2 of the largest barriers to participation. 3 To address this issue, the Veterans Health Administration (VHA) has started implementing new home-based CR (HBCR) programs. 4 ,5 Therefore, we examined whether 
